Effects of Melatonin, P-chlorophenylalanine, and α-methylparatyrosine on Plasma Gonadotropin Level and Ovarian Activity in the Catfish, Heteropneustes Fossilis: A Study Correlating Changes in Hypothalamic Monoamines
Overview
Authors
Affiliations
The effects of (ip, 10 injections over 20 days) of melatonin (75 μg 100 g(-1) BW), the serotonin (5-HT)-synthesis blocker, para-cholorophenylalanine (p-CPA, 10 mg 100g(-1 BW)) and the catecholamine-synthesis blocker, α-methylparatyrosine (α-MPT, 10 mg 100 g(-1) BW) on gonadotropin (GTH) secretion and ovarian activity were studied in (Heteropneustes fossilis) during late preparatory to early prespawning (April-May). The treatments resulted in significant reductions of plasma GTH and estradiol-17β levels, the gonadosomatic index, frequency distribution of vitellogenic and postvitellogenic oocytes, and ovarian and serum (32)p-labelled alkali-labile phosphoprotein (a marker of vitellogenic activity). Most of the oocytes were nonvitellogenic or had undergone atretic changes. The hepatic (32)-phosphoprotein content increased significantly over the saline control value. The effects were similar and pronounced in the p-CPA and melatonin-treated groups but were moderate in the α-MPT-treated group. Hypothalamic 5-HT content and turnover were significantly inhibited in the p-CPA and melatonin-treated groups but the content and turnover of catecholamines were not. The α-MPT treatment decreased significantly the content and turnover of dopamine (DA), noradrenaline (NA), and adrenaline (A) but did not influence the 5-HT content or turnover. These results suggest that 5-HT, NA and A are stimulatory to GTH secretion and that melatonin may act on the serotonergic system to inhibit the pituitary-gonadal axis.
Advances in Reproductive Endocrinology and Neuroendocrine Research Using Catfish Models.
Senthilkumaran B, Kar S Cells. 2021; 10(11).
PMID: 34831032 PMC: 8616529. DOI: 10.3390/cells10112807.
Effects of Melatonin on Anterior Pituitary Plasticity: A Comparison Between Mammals and Teleosts.
Ciani E, Haug T, Maugars G, Weltzien F, Falcon J, Fontaine R Front Endocrinol (Lausanne). 2021; 11:605111.
PMID: 33505357 PMC: 7831660. DOI: 10.3389/fendo.2020.605111.
Chaube R, Joy K Endocrine. 2011; 40(3):394-9.
PMID: 21994011 DOI: 10.1007/s12020-011-9543-5.